MedPath
Found 4 clinical trials|View Analysis
Sort by:

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

Phase 4
Withdrawn
Conditions
Venous Leg Ulcer
Varicose Veins Leg
Leg Ulcer
Veins, Varicose
Venous Reflux
Varicose Veins
Venous Ulcer
Reflux
Varicose Ulcer
Interventions
First Posted Date
2016-12-09
Last Posted Date
2017-09-15
Lead Sponsor
OhioHealth
Registration Number
NCT02988063
Locations
🇺🇸

OhioHealth Riverside Methodist Hospital, Columbus, Ohio, United States

Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)

Phase 1
Completed
Conditions
Varicose Veins
Interventions
First Posted Date
2011-09-02
Last Posted Date
2021-04-21
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
21
Registration Number
NCT01428076
Locations
🇺🇸

Cardiovascular and Vein Center of Florida, Bradenton, Florida, United States

Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence

First Posted Date
2010-11-01
Last Posted Date
2021-04-21
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
235
Registration Number
NCT01231373

An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins

Phase 2
Completed
Conditions
Varicose Veins
Interventions
First Posted Date
2009-06-26
Last Posted Date
2021-05-13
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
16
Registration Number
NCT00928421
© Copyright 2025. All Rights Reserved by MedPath